Tufts CSDD
The Tufts Center for the Study of Drug Development is an independent, academic, non-profit research group that provides strategic information on improving the quality and efficiency of pharmaceutical development, research, and utilization. Drug development Research-based pharmaceutical industry Pharmaceutical innovation Biotechnology Biopharmaceutical FDA Food and Drug Administration Regulatory approval User fee Therapeutic agent Prescription drug Cost of new drug development Approval time Phase length Impact Report Tufts Center for the Study of Drug Development Tufts CSDD Institute Clinical pharmacology Performance Benchmarking DIA Drug Information Association PhRMA Tufts postmarketing public policy workshops global R&D R&D costs R&D R&D productivity research and development prescription drug regulatory formulary orphan drug PDUFA PDUFA III PDUFA IV biologics biological approval success rates fast track programs clinical phases managed care medicare medicare's prescription drug educational programs drug discovery blockbuster drugs FDAs critical path post approval research FDA NMEs NCEs INDs approval phase approval times patient outcomes
November 09, 2009 at 02:43:24 AM OK Yes More Information about this website: Internet Wayback Machine Google's Cache Whois Source (Detailed Information) BookmarkSync is a unique service that provides all of the benefits of social bookmarking without compromising your privacy. No tags to enter and all of the tools for finding great new websites!
|
|
|||||||||||||||